tirzepatide medullary thyroid cancer Investigating FDA Reports of Tirzepatide-Thyroid

For those on insulin or sulphonylureas, a slightly higher target of 53 mmol/mol (7.0%) may be more appropriate to reduce hypoglycaemia risk

When researchers evaluated treatment options for adults living with type 2 diabetes, Mounjaro and Ozempic were studied side by side

Disclaimer: This post is intended for public health awareness only and should not be considered medical advice

Liability Limitation Statement: By reading and using the information contained herein, the reader agrees to release the publisher, content creators, affiliates, and distribution partners from any and all liability, including but not limited to direct, indirect, incidental, punitive, and consequential damages arising out of the use of the content or products mentioned

No robust randomised study was identified comparing KLOW with placebo, standard care or any individual component